Heat Biologics Current Ratio 2013-2019 | HTBX

Heat Biologics current ratio from 2013 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Heat Biologics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-06-30 $0.02B $0.00B 4.50
2019-03-31 $0.02B $0.00B 5.70
2018-12-31 $0.03B $0.01B 5.89
2018-09-30 $0.02B $0.01B 3.45
2018-06-30 $0.03B $0.01B 3.88
2018-03-31 $0.01B $0.01B 1.11
2017-12-31 $0.01B $0.01B 1.14
2017-09-30 $0.01B $0.00B 1.98
2017-06-30 $0.01B $0.00B 2.77
2017-03-31 $0.01B $0.00B 7.67
2016-12-31 $0.01B $0.00B 5.18
2016-09-30 $0.01B $0.00B 2.71
2016-06-30 $0.01B $0.01B 1.61
2016-03-31 $0.01B $0.01B 2.04
2015-12-31 $0.01B $0.01B 1.80
2015-09-30 $0.02B $0.01B 3.15
2015-06-30 $0.02B $0.00B 6.75
2015-03-31 $0.02B $0.00B 9.86
2014-12-31 $0.02B $0.00B 5.94
2014-09-30 $0.02B $0.00B 12.80
2014-06-30 $0.02B $0.00B 16.87
2014-03-31 $0.02B $0.00B 26.86
2013-12-31 $0.02B $0.00B 19.43
2013-09-30 $0.02B $0.00B 42.66
2013-06-30 $0.00B $0.00B 2.05
2013-03-31 $0.00B 0.00
2012-12-31 $0.00B $0.00B 0.10
2012-09-30 $0.00B 0.00
2012-06-30 $0.00B 0.00
2012-03-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.020B $0.006B
Heat Biologics, Inc. is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of various cellular therapeutic vaccines for a range of cancers and infectious diseases. The Company's products under development include HS-110 for the treatment of non-small cell lung cancer, HS-410 for the bladder cancer treatment, HS-310 to treat ovarian cancer and HS-510 for treating triple negative breast cancer. Heat Biologics, Inc. is based in Chapel Hill, North Carolina.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $58.463B 36.01
Astellas Pharma (ALPMY) Japan $27.878B 13.28
Takeda Pharmaceutical (TAK) Japan $27.185B 8.49
UCB SA (UCBJF) Belgium $14.267B 0.00
Eisai (ESALY) Japan $14.254B 24.51
Merck (MKGAF) Germany $14.152B 19.31
Grifols, S.A (GRFS) Spain $13.648B 17.41
Ono Pharmaceutical (OPHLF) Japan $9.383B 20.06
Neurocrine Biosciences (NBIX) United States $9.287B 0.00
Ionis Pharmaceuticals (IONS) United States $9.102B 19.63
IPSEN SA ADR (IPSEY) France $8.529B 0.00
Sage Therapeutics (SAGE) United States $8.489B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.461B 9.82
Catalent (CTLT) United States $7.424B 29.39
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.781B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $5.052B 18.16
United Therapeutics (UTHR) United States $3.765B 0.00
Nektar Therapeutics (NKTR) United States $3.628B 0.00
FibroGen (FGEN) United States $3.599B 90.02
Evotec AG (EVTCY) Germany $3.399B 46.53
Taro Pharmaceutical Industries (TARO) Israel $3.166B 11.35
Tilray (TLRY) Canada $2.978B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.801B 64.22
PTC Therapeutics (PTCT) United States $2.554B 0.00
Portola Pharmaceuticals (PTLA) United States $2.102B 0.00
Xencor (XNCR) United States $2.068B 45.10
Zogenix (ZGNX) United States $1.887B 0.00
Heron Therapeutics (HRTX) United States $1.707B 0.00
USANA Health Sciences (USNA) United States $1.588B 15.92
Pacira Pharmaceuticals (PCRX) United States $1.580B 57.50
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
Corcept Therapeutics (CORT) United States $1.534B 21.08
Ironwood Pharmaceuticals (IRWD) United States $1.490B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.357B 22.39
Radius Health (RDUS) United States $1.343B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.283B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.065B 0.00
Aerie Pharmaceuticals (AERI) United States $1.047B 0.00
ArQule (ARQL) United States $0.952B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.948B 4.23
Endo (ENDP) Ireland $0.928B 1.63
TherapeuticsMD (TXMD) United States $0.921B 0.00
Karyopharm Therapeutics (KPTI) United States $0.723B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.676B 0.00
Concordia (CXRXF) Canada $0.674B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.586B 0.00
Akebia Therapeutics (AKBA) United States $0.566B 0.00
Translate Bio (TBIO) United States $0.561B 0.00
Lannett Co Inc (LCI) United States $0.556B 5.86
Organogenesis Holdings (ORGO) United States $0.552B 0.00
Flexion Therapeutics (FLXN) United States $0.552B 0.00
Aptorum Group (APM) China $0.492B 0.00
ImmunoGen (IMGN) United States $0.481B 0.00
Dermira (DERM) United States $0.472B 0.00
Indivior (INVVY) United States $0.468B 1.69
Siga Technologies (SIGA) United States $0.467B 1.09
Innate Pharma SA (IPHYF) France $0.455B 0.00
Dova Pharmaceuticals (DOVA) United States $0.450B 0.00
ChemoCentryx (CCXI) United States $0.440B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.428B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.426B 19.39
Collegium Pharmaceutical (COLL) United States $0.406B 0.00
Harpoon Therapeutics (HARP) United States $0.379B 0.00
DURECT (DRRX) United States $0.365B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.361B 0.00
OptiNose (OPTN) United States $0.347B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.321B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.307B 0.00
CV Sciences (CVSI) United States $0.302B 0.00
Ardelyx (ARDX) United States $0.294B 0.00
Xeris Pharmaceuticals (XERS) United States $0.290B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.278B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.277B 0.00
Rafael Holdings (RFL) United States $0.272B 0.00
Recro Pharma (REPH) United States $0.268B 0.00
Concert Pharmaceuticals (CNCE) United States $0.264B 0.00
KalVista Pharmaceuticals (KALV) United States $0.261B 0.00
Molecular Templates (MTEM) United States $0.236B 0.00
Calithera Biosciences (CALA) United States $0.215B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.215B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.207B 0.00
Ocular Therapeutix (OCUL) United States $0.203B 0.00
GlycoMimetics (GLYC) United States $0.203B 0.00
Nature's Sunshine Products (NATR) United States $0.189B 31.55
CannTrust Holdings (CTST) Canada $0.183B 0.00
Generex Biotechnology (GNBT) United States $0.174B 0.00
Redhill Biopharma (RDHL) Israel $0.169B 0.00
Taiwan Liposome (TLC) Taiwan $0.160B 0.00
IMV INC (IMV) Canada $0.155B 0.00
MEI Pharma (MEIP) United States $0.142B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.135B 0.00
Cardiome Pharma (CORV) Canada $0.126B 0.00
ElectroCore (ECOR) United States $0.120B 0.00
Jounce Therapeutics (JNCE) United States $0.112B 0.00
Majesco Entertainment (PTE) United States $0.109B 0.00
Mast Therapeutics (SVRA) United States $0.108B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.106B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.105B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.104B 0.00
Neos Therapeutics (NEOS) United States $0.094B 0.00
AgeX Therapeutics (AGE) United States $0.093B 0.00
Genocea Biosciences (GNCA) United States $0.092B 0.00
MediWound (MDWD) Israel $0.092B 0.00
Aquestive Therapeutics (AQST) United States $0.091B 0.00
Iterum Therapeutics (ITRM) Ireland $0.091B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.089B 0.00
RENEURON GP (RNUGF) United Kingdom $0.084B 0.00
Nivalis Therapeutics (ALPN) United States $0.077B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.075B 28.59
Aclaris Therapeutics (ACRS) United States $0.074B 0.00
Jaguar Animal Health (JAGX) United States $0.074B 0.00
Natural Alternatives (NAII) United States $0.073B 7.30
Lipocine (LPCN) United States $0.070B 0.00
Novan (NOVN) United States $0.070B 0.00
Champions Oncology (CSBR) United States $0.069B 592.00
Infinity Pharmaceuticals (INFI) United States $0.068B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.067B 0.00
Otonomy (OTIC) United States $0.066B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.062B 0.00
SCYNEXIS (SCYX) United States $0.061B 0.00
China SXT Pharmaceuticals (SXTC) China $0.059B 0.00
Capnia (SLNO) United States $0.058B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.053B 0.00
CTI BioPharma (CTIC) United States $0.049B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.047B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.046B 0.00
Melinta Therapeutics (MLNT) United States $0.046B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.046B 1.59
Forward Pharma (FWP) Denmark $0.045B 0.00
India Globalization Capital (IGC) United States $0.042B 0.00
Mannatechorporated (MTEX) United States $0.039B 0.00
Bio-Path Holdings (BPTH) United States $0.034B 0.00
Opexa Therapeutics (ACER) United States $0.034B 0.00
PharmAthene (ALT) United States $0.033B 0.00
Biomerica (BMRA) United States $0.031B 0.00
IsoRay (ISR) United States $0.021B 0.00
ProPhase Labs (PRPH) United States $0.019B 0.00
Achieve Life Sciences (ACHV) United States $0.018B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.018B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
HANCOCK JAFFE (HJLI) United States $0.017B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.016B 0.00
Vical (BBI) United States $0.015B 0.00
Shineco (TYHT) China $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.013B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
Onconova Therapeutics (ONTX) United States $0.011B 0.00
VAXART, INC (VXRT) United States $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Hemispherx BioPharma (AIM) United States $0.004B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00